BioCentury
ARTICLE | Clinical News

Rebif: Began Phase II/III trial

October 4, 1993 7:00 AM UTC

Ares-Serono Group Product: Rebif, recombinant beta interferon Indication: Treat relapsing-remitting multiple sclerosis Status: Began Phase II/III trial in Europe and plans to initiate Phase II/III tr...